Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue
Standard
Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue. / Hoffmann, Linda S; Etzrodt, Jennifer; Willkomm, Lena; Sanyal, Abhishek; Scheja, Ludger; Fischer, Alexander W C; Stasch, Johannes-Peter; Bloch, Wilhelm; Friebe, Andreas; Heeren, Joerg; Pfeifer, Alexander.
in: NAT COMMUN, Jahrgang 6, 05.2015, S. Art. 7235.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue
AU - Hoffmann, Linda S
AU - Etzrodt, Jennifer
AU - Willkomm, Lena
AU - Sanyal, Abhishek
AU - Scheja, Ludger
AU - Fischer, Alexander W C
AU - Stasch, Johannes-Peter
AU - Bloch, Wilhelm
AU - Friebe, Andreas
AU - Heeren, Joerg
AU - Pfeifer, Alexander
PY - 2015/5
Y1 - 2015/5
N2 - Obesity is characterized by a positive energy balance and expansion of white adipose tissue (WAT). In contrast, brown adipose tissue (BAT) combusts energy to produce heat. Here we show that a small molecule stimulator (BAY 41-8543) of soluble guanylyl cyclase (sGC), which produces the second messenger cyclic GMP (cGMP), protects against diet-induced weight gain, induces weight loss in established obesity, and also improves the diabetic phenotype. Mechanistically, the haeme-dependent sGC stimulator BAY 41-8543 enhances lipid uptake into BAT and increases whole-body energy expenditure, whereas ablation of the haeme-containing β1-subunit of sGC severely impairs BAT function. Notably, the sGC stimulator enhances differentiation of human brown adipocytes as well as induces 'browning' of primary white adipocytes. Taken together, our data suggest that sGC is a potential pharmacological target for the treatment of obesity and its comorbidities.
AB - Obesity is characterized by a positive energy balance and expansion of white adipose tissue (WAT). In contrast, brown adipose tissue (BAT) combusts energy to produce heat. Here we show that a small molecule stimulator (BAY 41-8543) of soluble guanylyl cyclase (sGC), which produces the second messenger cyclic GMP (cGMP), protects against diet-induced weight gain, induces weight loss in established obesity, and also improves the diabetic phenotype. Mechanistically, the haeme-dependent sGC stimulator BAY 41-8543 enhances lipid uptake into BAT and increases whole-body energy expenditure, whereas ablation of the haeme-containing β1-subunit of sGC severely impairs BAT function. Notably, the sGC stimulator enhances differentiation of human brown adipocytes as well as induces 'browning' of primary white adipocytes. Taken together, our data suggest that sGC is a potential pharmacological target for the treatment of obesity and its comorbidities.
U2 - 10.1038/ncomms8235
DO - 10.1038/ncomms8235
M3 - SCORING: Journal article
C2 - 26011238
VL - 6
SP - Art. 7235
JO - NAT COMMUN
JF - NAT COMMUN
SN - 2041-1723
ER -